The fallout from the F.D.A.’s rejection of a new treatment for PTSD worries researchers and experts who fear other psychedelic drugs in the pipeline could be jeopardized.
Related Posts
E.T.F.s Are Booming. Mutual Funds Want In on the Action.
Asset managers are eagerly awaiting an S.E.C. decision that would allow mutual funds to also trade as E.T.F.s — potentially changing how trillions of dollars […]
Meat Is Back at Eleven Madison Park, After 4 Vegan Years
The Manhattan restaurant drew global praise and skepticism with its climate-minded, all-plant menu. Now its chef wants to be more welcoming — and popular.
Adidas Has Sold Its Last Yeezy Sneaker
The sportswear maker was eager to put the scandal with the rapper Ye behind it, but its cautious earnings forecast showed the breakup’s effects still […]